|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 219.57 USD | +0.47% |
|
+5.82% | +6.10% |
| Jan. 15 | Investors bank on US earnings strength as policy noise grows louder | RE |
| Jan. 15 | Wall St Week Ahead-Investors bank on US earnings strength as policy noise grows louder | RE |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 7.52 | 8.84 | 8.71 | 8.33 | 8.13 | |||||
Return on Total Capital | 13.32 | 15.14 | 14.21 | 13.65 | 13.55 | |||||
Return On Equity % | 23.97 | 30.41 | 23.79 | 18.31 | 20.06 | |||||
Return on Common Equity | 23.97 | 30.41 | 23.79 | 18.31 | 20.06 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 65.7 | 68.27 | 67.36 | 69.18 | 69.56 | |||||
SG&A Margin | 26.74 | 25.66 | 24.86 | 23.68 | 24.71 | |||||
EBITDA Margin % | 32.99 | 34.8 | 34.46 | 36.13 | 33.71 | |||||
EBITA Margin % | 29.93 | 31.93 | 31.65 | 33.07 | 30.51 | |||||
EBIT Margin % | 24.23 | 26.92 | 27.12 | 27.79 | 25.45 | |||||
Income From Continuing Operations Margin % | 17.82 | 22.26 | 18.9 | 15.65 | 15.84 | |||||
Net Income Margin % | 17.82 | 22.26 | 18.9 | 41.28 | 15.84 | |||||
Net Avail. For Common Margin % | 17.82 | 22.26 | 18.9 | 15.65 | 15.84 | |||||
Normalized Net Income Margin | 15.28 | 17.24 | 18.08 | 18.68 | 17.2 | |||||
Levered Free Cash Flow Margin | 26.46 | 20.07 | 20.21 | 23.24 | 18.76 | |||||
Unlevered Free Cash Flow Margin | 26.62 | 20.19 | 20.39 | 23.8 | 19.29 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.5 | 0.53 | 0.51 | 0.48 | 0.51 | |||||
Fixed Assets Turnover | 4.3 | 4.73 | 4.66 | 4.27 | 4.18 | |||||
Receivables Turnover (Average Receivables) | 5.89 | 6.5 | 6.04 | 5.89 | 5.98 | |||||
Inventory Turnover (Average Inventory) | 3.09 | 3.02 | 2.71 | 2.45 | 2.29 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.21 | 1.35 | 0.99 | 1.16 | 1.11 | |||||
Quick Ratio | 0.92 | 1.04 | 0.71 | 0.82 | 0.78 | |||||
Operating Cash Flow to Current Liabilities | 0.55 | 0.52 | 0.38 | 0.49 | 0.48 | |||||
Days Sales Outstanding (Average Receivables) | 63.02 | 56.01 | 60.27 | 61.79 | 60.89 | |||||
Days Outstanding Inventory (Average Inventory) | 120.26 | 120.69 | 134.32 | 148.75 | 159.04 | |||||
Average Days Payable Outstanding | 116.86 | 121.5 | 125.19 | 130.83 | 128.26 | |||||
Cash Conversion Cycle (Average Days) | 66.42 | 55.2 | 69.4 | 79.71 | 91.67 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 57.47 | 46.95 | 53.33 | 44.25 | 52.92 | |||||
Total Debt / Total Capital | 36.5 | 31.95 | 34.78 | 30.68 | 34.61 | |||||
LT Debt/Equity | 53.31 | 41.86 | 36.7 | 39.23 | 44.55 | |||||
Long-Term Debt / Total Capital | 33.86 | 28.49 | 23.94 | 27.2 | 29.13 | |||||
Total Liabilities / Total Assets | 63.82 | 59.33 | 59.01 | 58.96 | 60.31 | |||||
EBIT / Interest Expense | 99.57 | 137.96 | 93.29 | 30.65 | 29.94 | |||||
EBITDA / Interest Expense | 137.04 | 179.98 | 119.63 | 40.11 | 39.92 | |||||
(EBITDA - Capex) / Interest Expense | 120.39 | 160.03 | 105.1 | 33.62 | 34.06 | |||||
Total Debt / EBITDA | 1.32 | 1.06 | 1.24 | 0.98 | 1.26 | |||||
Net Debt / EBITDA | 0.34 | 0.1 | 0.53 | 0.24 | 0.44 | |||||
Total Debt / (EBITDA - Capex) | 1.5 | 1.19 | 1.41 | 1.17 | 1.47 | |||||
Net Debt / (EBITDA - Capex) | 0.39 | 0.11 | 0.6 | 0.29 | 0.52 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 0.64 | 13.55 | 1.25 | 6.46 | 4.3 | |||||
Gross Profit, 1 Yr. Growth % | -0.45 | 18.21 | 0.05 | 6.36 | 4.52 | |||||
EBITDA, 1 Yr. Growth % | -2.62 | 18.49 | 0.54 | 7.92 | -3.32 | |||||
EBITA, 1 Yr. Growth % | -2.97 | 19.72 | 0.66 | 7.99 | -4.45 | |||||
EBIT, 1 Yr. Growth % | -4.56 | 24.28 | 2.37 | 6.69 | -5.29 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -2.68 | 41.89 | -14.07 | -18.6 | 5.55 | |||||
Net Income, 1 Yr. Growth % | -2.68 | 41.89 | -14.07 | 95.94 | -59.99 | |||||
Normalized Net Income, 1 Yr. Growth % | -6.69 | 27.84 | 3.97 | 6.7 | -5.07 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -2.13 | 41.74 | -13.83 | -15.31 | 11.35 | |||||
Accounts Receivable, 1 Yr. Growth % | -6.25 | 12.57 | 5.74 | 5.94 | -0.21 | |||||
Inventory, 1 Yr. Growth % | 3.59 | 11.16 | 20.18 | 8.89 | 11.3 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 5.94 | 0.49 | 5.24 | 10.09 | 3.45 | |||||
Total Assets, 1 Yr. Growth % | 10.88 | 4.07 | 2.94 | -10.58 | 7.49 | |||||
Tangible Book Value, 1 Yr. Growth % | 21.58 | -71.28 | 119.99 | -186.38 | 427.21 | |||||
Common Equity, 1 Yr. Growth % | 6.4 | 16.98 | 3.76 | -10.46 | 3.95 | |||||
Cash From Operations, 1 Yr. Growth % | 0.51 | -0.54 | -9.47 | 7.54 | 6.47 | |||||
Capital Expenditures, 1 Yr. Growth % | -4.32 | 9.11 | 9.78 | 25.04 | -2.62 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -11.23 | -13.69 | 2.28 | 31.12 | -16.31 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -11.43 | -13.67 | 2.58 | 32.8 | -15.98 | |||||
Dividend Per Share, 1 Yr. Growth % | 6.13 | 5.28 | 6.21 | 5.62 | 4.47 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 0.61 | 6.9 | 7.22 | 4 | 5.38 | |||||
Gross Profit, 2 Yr. CAGR % | -0.21 | 8.38 | 8.67 | 3.18 | 5.61 | |||||
EBITDA, 2 Yr. CAGR % | -1.54 | 7.44 | 9.08 | 4.44 | 2.48 | |||||
EBITA, 2 Yr. CAGR % | -1.7 | 7.81 | 9.7 | 4.57 | 1.94 | |||||
EBIT, 2 Yr. CAGR % | -2.78 | 8.97 | 12.71 | 4.78 | 0.94 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -1.92 | 17.51 | 10.42 | -13.48 | -7.3 | |||||
Net Income, 2 Yr. CAGR % | -1.92 | 17.51 | 10.42 | 29.76 | -11.46 | |||||
Normalized Net Income, 2 Yr. CAGR % | 1.96 | 22.91 | 26.93 | 10.99 | 6.5 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -0.9 | 17.78 | 10.52 | -11.64 | -2.89 | |||||
Accounts Receivable, 2 Yr. CAGR % | -1.87 | 2.73 | 9.1 | -1.35 | 2.82 | |||||
Inventory, 2 Yr. CAGR % | 4.24 | 7.31 | 15.58 | 3.75 | 10.09 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 7.72 | 3.18 | 2.84 | 2.57 | 6.72 | |||||
Total Assets, 2 Yr. CAGR % | 6.93 | 7.42 | 3.51 | -4.05 | -1.96 | |||||
Tangible Book Value, 2 Yr. CAGR % | 20.34 | -40.91 | -20.52 | -49.28 | 113.4 | |||||
Common Equity, 2 Yr. CAGR % | 2.91 | 11.57 | 10.17 | -3.61 | -3.52 | |||||
Cash From Operations, 2 Yr. CAGR % | 2.96 | -0.01 | -5.11 | -1.33 | 7 | |||||
Capital Expenditures, 2 Yr. CAGR % | -4.5 | 2.18 | 9.44 | 17.16 | 5.05 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 12.57 | -12.9 | -6.13 | 12.02 | 5.08 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 10.89 | -12.98 | -5.98 | 12.97 | 5.96 | |||||
Dividend Per Share, 2 Yr. CAGR % | 6.03 | 5.7 | 5.74 | 5.91 | 5.04 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 2.61 | 4.75 | 4.98 | 1.03 | 4.1 | |||||
Gross Profit, 3 Yr. CAGR % | 2.08 | 5.52 | 5.47 | 2.85 | 3.74 | |||||
EBITDA, 3 Yr. CAGR % | 3.55 | 5.11 | 4.99 | 3.82 | 2.01 | |||||
EBITA, 3 Yr. CAGR % | 4.12 | 5.4 | 5.26 | 4.1 | 1.71 | |||||
EBIT, 3 Yr. CAGR % | 1.93 | 6.04 | 6.59 | 5.3 | 1.59 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 124.52 | 10.92 | 5.87 | -3.25 | -7.55 | |||||
Net Income, 3 Yr. CAGR % | 124.52 | 10.92 | 5.87 | 33.68 | -12.33 | |||||
Normalized Net Income, 3 Yr. CAGR % | 4.13 | 10.04 | 17.05 | 14.3 | 5.77 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 127.17 | 11.66 | 6.13 | -1.91 | -4.56 | |||||
Accounts Receivable, 3 Yr. CAGR % | 0.21 | 2.73 | 3.72 | 3.09 | -0.97 | |||||
Inventory, 3 Yr. CAGR % | 2.16 | 6.5 | 11.44 | 6.17 | 6.21 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 5.14 | 5.25 | 3.86 | 1.87 | 2.86 | |||||
Total Assets, 3 Yr. CAGR % | 3.6 | 5.97 | 5.91 | -1.42 | -0.35 | |||||
Tangible Book Value, 3 Yr. CAGR % | 2.02 | -25.36 | -8.42 | -58.04 | 10.69 | |||||
Common Equity, 3 Yr. CAGR % | 1.7 | 7.4 | 8.9 | 2.82 | -1.15 | |||||
Cash From Operations, 3 Yr. CAGR % | 3.78 | 1.78 | -3.27 | -1.07 | 1.2 | |||||
Capital Expenditures, 3 Yr. CAGR % | 0.69 | -0.16 | 4.65 | 14.41 | 6.6 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 6.87 | 2.95 | -8.2 | -3.13 | 1.86 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 5.94 | 1.93 | -8.17 | -2.54 | 2.56 | |||||
Dividend Per Share, 3 Yr. CAGR % | 6.23 | 5.78 | 5.87 | 5.7 | 5.43 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 3.34 | 5.46 | 4.43 | 0.86 | 1.6 | |||||
Gross Profit, 5 Yr. CAGR % | 2.22 | 5.03 | 4.63 | 1.57 | 2.54 | |||||
EBITDA, 5 Yr. CAGR % | 4.26 | 5.54 | 5.92 | 1.83 | 1.15 | |||||
EBITA, 5 Yr. CAGR % | 4.78 | 6.01 | 6.53 | 1.95 | 1.02 | |||||
EBIT, 5 Yr. CAGR % | 1.73 | 3.59 | 6.38 | 2.25 | 1.23 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -0.92 | 4.77 | 69.04 | -2.72 | -1.43 | |||||
Net Income, 5 Yr. CAGR % | -0.92 | 4.77 | 69.04 | 18.11 | -1.43 | |||||
Normalized Net Income, 5 Yr. CAGR % | 2.03 | 5.24 | 8.97 | 5.56 | 7.38 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 0.11 | 5.66 | 70.29 | -1.51 | 0.56 | |||||
Accounts Receivable, 5 Yr. CAGR % | 4.81 | 5.49 | 3.68 | 1.08 | 0.49 | |||||
Inventory, 5 Yr. CAGR % | 3.02 | 4.99 | 7.33 | 5.39 | 6.65 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 4.44 | 4.53 | 4.21 | 4.17 | 2.99 | |||||
Total Assets, 5 Yr. CAGR % | 5.56 | 5.21 | 3.56 | 1.84 | 2.69 | |||||
Tangible Book Value, 5 Yr. CAGR % | 2.22 | -18.16 | -7.68 | -36.05 | -13.89 | |||||
Common Equity, 5 Yr. CAGR % | -2.32 | 1 | 5.01 | 2.85 | 3.75 | |||||
Cash From Operations, 5 Yr. CAGR % | 3.76 | 4.52 | 0.13 | 0.53 | 0.72 | |||||
Capital Expenditures, 5 Yr. CAGR % | -0.68 | 2.51 | 4.1 | 6.44 | 4.81 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 11.88 | 6.48 | 1.39 | 2.79 | -7.64 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 11.39 | 5.92 | 0.92 | 2.55 | -7.27 | |||||
Dividend Per Share, 5 Yr. CAGR % | 6.17 | 5.87 | 6.03 | 5.83 | 5.54 |
- Stock Market
- Equities
- JNJ Stock
- Financials Johnson & Johnson
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















